Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005304243 | SCV005956368 | uncertain significance | Inborn genetic diseases | 2025-01-17 | criteria provided, single submitter | clinical testing | The c.13699C>T (p.L4567F) alteration is located in exon 63 (coding exon 62) of the USH2A gene. This alteration results from a C to T substitution at nucleotide position 13699, causing the leucine (L) at amino acid position 4567 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |